Review Article
Small Cell Carcinoma of the Gallbladder: Case Report and Comprehensive Analysis of Published Cases
Table 1
Clinical characteristics in local disease.
| ā | Year | Age | Sex | Histology | Stones | Surgery | Adjuvant chemotherapy | Adjuvant radiation | Survival | Ref. |
| 1 | 1988 | 72 | F | SCC | No | Yes | None | No | 2 | [17] | 2 | 1988 | 68 | F | SCC | Yes | Yes | None | No | >59 | [17] | 3 | 1990 | 72 | F | SCC | Yes | Yes | None | No | >12 | [18] | 4 | 1993 | 74 | M | SCC | N/A | Yes | None | No | >28 | [19] | 5 | 1993 | 61 | M | SCC | Yes | Yes | Etop. | No | 2 | [14] | 6 | 1994 | 71 | F | SCC, adenosquamous | Yes | Yes | None | No | 20 | [20] | 7 | 1998 | 76 | F | SCC | No | Yes | None | No | >144 | [21] | 8 | 1999 | 57 | F | SCC | No | Yes | 5-FU | Yes | 31 | [31] | 9 | 1999 | 40 | M | SCC, moderately differentiated adenocarcinoma | Yes | Yes | 5-FU | No | >189 | [31] | 10 | 1999 | 79 | M | SCC | No | Yes | Cyclophos., Vinc., Procarb., Pred. | No | 3.5 | [22] | 11 | 1999 | 86 | F | SCC | Yes | Yes | None | No | 5 | [22] | 12 | 2000 | 25 | F | SCC | N/A | Yes | None | Yes | >7 | [10] | 13 | 2000 | 81 | F | SCC | Yes | Yes | None | No | >5 | [12] | 14 | 2002 | 67 | M | SCC, undifferentiated with neuroendocrine features | Yes | No | Cis., Etop. | Yes | 11 | [23] | 15 | 2002 | 66 | F | SCC, clear cell carcinoma, and adenocarcinoma | Yes | Yes | Chemo N/A | No | 36 | [24] | 16 | 2009 | 48 | F | SCC | No | Yes | Cis., Etop. | No | >4 | [9] | 17 | 2010 | 47 | M | SCC | No | Yes | Cis., Etop. | Yes | >8 | [25] | 18 | 2010 | 41 | F | SCC | No | Yes | Chemo N/A | No | >2 | [25] | 19 | 2010 | 70 | F | SCC | N/A | Yes | Cis., Etop. | Yes | >15 | [6] |
|
|
SCC = small cell carcinoma; Etop. = etoposide; Cyclophos. = cyclophosphamide; Vinc. = vincristine; Procarb. = procarbazine; Pred. = prednisolone; Cis. = cisplatin; chemo N/A = chemotherapy (agents not identified).
|